Papers

3

Total Citations

36

H-Index

3

About

Greg Hruby is a urologic surgeon and researcher whose work focuses on refining surgical outcomes in robot-assisted radical prostatectomy (RARP), particularly in the domains of thromboembolic prophylaxis and intraoperative technique. His most cited study, a 2011 case series on heparin prophylaxis, demonstrated that pharmacological prevention, combined with early mobilization, significantly reduces the risk of venous thromboembolism after RARP—a critical safety contribution that has informed perioperative protocols (25 citations). Hruby also investigated whether the da Vinci Surgical System exhibits an inherent “handedness” bias, finding no significant difference in lymph node yield or neurovascular bundle dissection between left and right approaches, thereby supporting the system’s claim of eliminating surgeon hand dominance (8 citations). Additionally, his work on routine apical margin biopsy during RARP questioned the necessity of this step given enhanced robotic visualization, suggesting that the robot’s improved apex visibility may reduce positive margin rates without additional biopsy (3 citations). These contributions, though modest in citation count, address practical, high-impact questions in urologic oncology—balancing safety, precision, and efficiency—making Hruby a thoughtful voice in the evolution of robotic surgery.

Research Focus

Key Achievements

3
H-Index
3
Papers
36
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Heparin prophylaxis and the risk of venous thromboembolism after robotic‐assisted laparoscopic prostatectomy
25 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Columbia University, Columbia University Irving Medical Center, NewYork–Presbyterian Hospital

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago